DUBLIN–(Business WIRE)–Jan 17, 2022–
This report is an analytical business tool that comprehensively evaluates the world market place for women’s well being therapeutics. The format of the study is arranged about the adhering to topics –
- Comprehensive examine close to women’s ailments, this sort of as endometriosis, postmenopausal osteoporosis, menopause, breast most cancers and PCOS.
- Sickness incidence and prevalence.
- Regulatory framework of pharmaceutical business.
- Market place characterization, unmet need, industry size and segmentation.
- Market motorists and restraints.
- Detailed industry projections through 2026.
- Level of competition and current market shares.
- Pricing and reimbursement.
- Marketed and pipeline (R&D) solutions alongside with description, regulatory standing, and scientific trials.
- Observations and conclusions regarding the foreseeable future of marketplace for women’s wellness therapeutics.
- Profiles of industry members and associations.
- 58 facts tables and 56 supplemental tables
- An overview of the worldwide current market and technologies for women’s overall health therapeutics
- Estimation of the marketplace dimensions and analyses of world-wide sector trends, with info from 2018, 2019, 2020, estimates for 2021 and projections of compound annual progress fees (CAGRs) by means of 2026
- Specific study about women’s disorders this sort of as endometriosis, postmenopausal osteoporosis, menopause, breast cancer and polycystic ovary syndrome (PCOS) their historic track record, levels, indications, threat aspects and genetic variables, prognosis, and remedy, etiology, pathophysiology, epidemiology, and financial load
- Discussion on getting old and women’s overall health conditions, women of all ages & sexual well being this sort of as feminine sexual arousal disorder, woman orgasmic ailment, and vaginismus and relation concerning infertility and cancer
- Coverage of regulatory structure, pricing, and reimbursement scenarios promoted and pipeline (R&D) items, and medical trials
- Identification of market motorists, restraints and other forces impacting the world wide marketplace and evaluation of present-day market size and forecast
- Sector share evaluation of the key firms of the marketplace and protection of their proprietary systems, strategic alliances, and other essential industry procedures
- Getting older Female Inhabitants
- Federal government Involvement and Enhanced Funding
- Raising Awareness Relating to Women’s Disorders and Treatment plans
- Lousy Diagnosis
- Availability of Alternate Procedure Alternatives and Life style Adjustments
- Unavailability of Novel Solutions
- High Cure Charge of Osteoporosis
- Soaring Feminine Populace in Asia-Pacific
- Enhanced Desire for Technology Innovation
- Abbvie Inc.
- Amgen Inc.
- Asahi Kasei
- Astrazeneca plc
- Bayer AG
- Bristol-Myers Squibb
- Daiichi Sankyo Co. Ltd.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences Inc.
- Johnson & Johnson Solutions Inc.
- Merck & Co. Inc.
- Merck Kgaa
- Novartis AG
- Novo Nordisk
- Pfizer Inc.
- Takeda Pharmaceutical Co. Ltd.
Laura Wooden, Senior Push Supervisor
For E.S.T Business office Several hours Simply call 1-917-300-0470
For U.S./CAN Toll No cost Connect with 1-800-526-8630
For GMT Place of work Several hours Call +353-1-416-8900
Field Key phrase: Wellness PHARMACEUTICAL
Source: Study and Markets
Copyright Business Wire 2022.
PUB: 01/17/2022 09:59 AM/DISC: 01/17/2022 09:59 AM
Copyright Enterprise Wire 2022.